Syndax Pharmaceuticals Welcomes New Board Member, Passes Resolutions
Company Announcements

Syndax Pharmaceuticals Welcomes New Board Member, Passes Resolutions

Syndax Pharmaceuticals Inc (SNDX) just unveiled an announcement.

Syndax Pharmaceuticals has announced the appointment of Aleksandra Rizo, M.D., Ph.D., to its Board of Directors and Science and Technology Committee, filling the vacancy left by Dr. Briggs W. Morrison’s resignation. Dr. Rizo will be compensated for her services and has been granted an option to purchase company stock, with vesting terms over three years. At the company’s annual meeting, all proposed resolutions passed, including the election of directors and approval of executive compensation, with detailed voting results provided for each proposal.

For a thorough assessment of SNDX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlySyndax price target raised to $47 from $45 at H.C. Wainwright
TipRanks Auto-Generated NewsdeskSyndax Pharmaceuticals: Key Pipeline Developments and Financial Update
TheFlySyndax reports Q3 EPS (98c), consensus ($1.11)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App